• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

XTL BioPharma(XTLB.US)

Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

May1
XTL BioPharma released FY2024 Q4 earnings on April 30 (EST), actual revenue USD 405 K, actual EPS USD -0.0909
03:00
XTL BioPharma released FY2024 annual earnings on April 30 (EST), actual revenue USD 451 K, actual EPS USD -0.2999
03:00
Apr30
XTL Biopharma Reports $1.03M Net Loss in Fiscal Year 2024
20:02
Dec31
XTL BioPharma released FY2024 Q3 earnings on December 30 (EST) with actual revenue of 46 K USD and EPS of -0.1333 USD
04:00
XTL BioPharma released FY2024 Semi-Annual Earnings on December 30 (EST) with actual revenue of 0 USD and EPS of -0.0401 USD
04:00
XTL BioPharma released FY2024 9 Months Earnings on December 30 (EST), with actual revenue of 46K USD and EPS of -0.1844 USD
04:00

Schedules & Filings

Schedules
Filings
Dec24
Reverse Stock Split(EST)

1-for-4 Reverse Stock Split

Apr30
Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 405 K, Net Income -255 K, EPS -0.0909

Dec30
Earning Release(EST)

FY2024 Q3 Earning Release (USD) Revenue 46 K, Net Income -553 K, EPS -0.1333

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INBS
11.510
+180.73%
+7.520
ANGH
3.918
+68.88%
+1.592
ESHA
21.700
+50.90%
+7.320
ESHAR
0.2500
+47.06%
+0.080
NCL
0.2754
+41.96%
+0.081
DVLT
0.6800
+31.66%
+0.169
RDACR
0.2493
+31.21%
+0.059
ULY
3.610
+30.80%
+0.900
SIDU
3.491
+30.76%
+0.830
ORIS
1.560
+27.87%
+0.340
View More